2019冠状病毒病的药物治疗与管理

IF 6.1 3区 医学 Q1 IMMUNOLOGY
Amy Hirsch Shumaker PharmD, BCPS, AAHIVP , Adarsh Bhimraj MD
{"title":"2019冠状病毒病的药物治疗与管理","authors":"Amy Hirsch Shumaker PharmD, BCPS, AAHIVP , Adarsh Bhimraj MD","doi":"10.1016/j.idc.2025.02.004","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13562,"journal":{"name":"Infectious disease clinics of North America","volume":"39 2","pages":"Pages 275-291"},"PeriodicalIF":6.1000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pharmacologic Treatment and Management of Coronavirus Disease 2019\",\"authors\":\"Amy Hirsch Shumaker PharmD, BCPS, AAHIVP , Adarsh Bhimraj MD\",\"doi\":\"10.1016/j.idc.2025.02.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":13562,\"journal\":{\"name\":\"Infectious disease clinics of North America\",\"volume\":\"39 2\",\"pages\":\"Pages 275-291\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2025-03-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infectious disease clinics of North America\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0891552025000091\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious disease clinics of North America","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0891552025000091","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

广泛的疫苗接种、混合免疫以及传播欧米克隆变异的致病性降低,降低了普通人群中2019年严重冠状病毒病(COVID-19)的发病率。某些COVID-19患者仍然面临严重后果的高风险。临床医生必须根据对轻中度COVID-19患者的预期益处和相对危害来个性化治疗。在过去几年中,针对重症和危重型COVID-19的指导治疗一直保持不变。关于免疫调节剂的数据提高了我们对重症和危重型COVID-19管理的理解,但在欧米克隆时代,这些药物的作用和使用时间仍然不确定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Pharmacologic Treatment and Management of Coronavirus Disease 2019
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.30
自引率
0.00%
发文量
75
审稿时长
6-12 weeks
期刊介绍: Infectious Disease Clinics of North America updates you on the latest trends in the clinical diagnosis and management of patients with infectious diseases, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in infectious disease, including clinical microbiology, compromised host infections, gastrointestinal infections, global health, hepatitis, HIV/AIDS, hospital-acquired infections, travel medicine, infection control, bacterial infections, sexually transmitted diseases, urinary tract infections, and viral infections.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信